Investigation of Novel 2-(Chloromethyl)-5-(3, 5-Disubstituted-1H-Indol-2-yl)-1,3,4-Oxadiazole Derivatives as In Vitro, and In Silico Bioactivity Potential: Anti-inflammatory, Anti-TB and Antioxidant Activities Study

被引:0
|
作者
Kumar, K. Harish [1 ]
Sridhar, B. T. [2 ]
Karunakar, Prashantha [3 ]
Nagesh, G. Y. [4 ]
Gupta, Nidhi [5 ]
Jisha, S. P. [6 ]
Basavarajaiah, S. M. [7 ]
机构
[1] Maharani Sci Coll Women, Dept Environm Sci, Mysore 570005, Karnataka, India
[2] Maharani Cluster Univ, Maharani Sci Coll Women, Dept Chem, Benagaluru 560001, Karnataka, India
[3] Visvesvaraya Technol Univ, Dayananda Sagar Coll Engn, Dept Biotechnol, Belagavi 560111, Karnataka, India
[4] Guru Nanak First Grade Coll, Dept Chem, Bidar 585403, Karnataka, India
[5] Maharishi Markandeshwar Deemed Univ, MM Coll Pharm, Ambala 133207, Haryana, India
[6] GFGC, Dept Chem, Benagaluru 560036, Karnataka, India
[7] Vijaya Coll, Post Grad Dept Chem, RV Rd, Bengaluru 560004, Karnataka, India
来源
CHEMISTRYSELECT | 2024年 / 9卷 / 33期
关键词
ADME; Anti-TB; Anti-oxidant; Cyclooxygenase; Indole; 1,3,4-Oxadiazole; Molecular docking; ANTIMICROBIAL ACTIVITY; 1,3,4-OXADIAZOLE;
D O I
暂无
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
A series of novel 2-(chloromethyl)-5-(3, 5-disubstituted-1H-indol-2-yl)-1,3,4-oxadiazole (3 a-h) derivatives have been synthesized as potential COX inhibitors, anti-TB, and anti-oxidant activities. The structures were confirmed by IR, NMR (1H and 13C) mass spectral techniques. The physicochemical properties, ADME, and drug-likeness profile for the synthesized compounds were evaluated by SwissADME. Based on our interest in indole chemistry and SAR study, foresaid indole compounds were examined for in vitro COX inhibitory activity, anti-TB, and antioxidant activities. The physicochemical and ADME studies were disclosed for newly synthesized compounds. The compounds 3 a,3 b and 3 c recognized outstanding COX-II inhibitions with IC50 values of 0.28, 0.24, and 0.45 mu M compared to standard drugs. The compounds 3 a,and3 b showed outstanding anti-TB activity with MIC value 0.78 mu g/mL. The compounds 3 a,3 b, and 3 c attested outstanding antioxidant activity at 10 mu g/ml with a rate of inhibition of 66.52 %, 68.25 %, and 65.95 % respectively. Finally, the molecular docking studies carried out with cyclooxygenase-2 (PDB ID: 6COX), M. tuberculosis enoyl reductase (INHA) complexed with 1-cyclohexyl-N-(3,5-dichlorophenyl)-5-oxopyrrolidine-3-carboxamide (PDB ID: 4TZK), and cytochrome c peroxidase (PDB ID: 2X08), for all the newly synthesized derivatives. Finally, selected compounds were taken for their molecular dynamic studies. A series of novel 2-(chloromethyl)-5-(3, 5-disubstituted-1H-indol-2-yl)-1,3,4-oxadiazole (3 a-h) derivatives have been synthesized as potential COX inhibitors, anti-TB, and anti-oxidant activities. The structures were confirmed by IR, NMR and mass spectral techniques. The physicochemical properties, ADME, and drug-likeness profile for the synthesized compounds were evaluated by SwissADME. Finally, these compounds were taken for their molecular modelling studies. image
引用
收藏
页数:12
相关论文
共 50 条
  • [21] Synthesis, Computational Studies, Antioxidant and Anti-Inflammatory Bio-Evaluation of 2,5-Disubstituted-1,3,4-Oxadiazole Derivatives
    Rana, Sibghat Mansoor
    Islam, Muhammad
    Saeed, Hamid
    Rafique, Hummera
    Majid, Muhammad
    Aqeel, Muhammad Tahir
    Imtiaz, Fariha
    Ashraf, Zaman
    PHARMACEUTICALS, 2023, 16 (07)
  • [22] Synthesis, Characterization, Anti-leishmanial Activity and in silico Studies of 5-(4-Methoxyphenyl)-2-(undecylthio)-1,3,4-oxadiazole
    Ahmed, Muhammad Naeem
    Ashraf, Iffat
    Yasin, Khawaja Ansar
    Sadiq-ur-Rehman
    Mehmood, Rashid
    Rashid, Umer
    Mahmood, Tariq
    Ayub, Khurshid
    Tahir, Muhammad Nawaz
    Khan, Abdul Majeed
    JOURNAL OF THE CHEMICAL SOCIETY OF PAKISTAN, 2018, 40 (04): : 773 - 781
  • [23] Crystal structure of 2-(adamantan-1-yl)-5-(4-bromophenyl)-1,3,4-oxadiazole
    Alzoman, Nourah Z.
    El-Emam, Ali A.
    Ghabbour, Hazem A.
    Kumar, C. S. Chidan
    Fun, Hoong-Kun
    ACTA CRYSTALLOGRAPHICA SECTION E-CRYSTALLOGRAPHIC COMMUNICATIONS, 2014, 70 : O1231 - +
  • [24] Synthesis, antimicrobial and anti-inflammatory activities of novel 5-(1-adamantyl)-1,3,4-thiadiazole derivatives
    Kadi, Adnan A.
    Al-Abdullah, Ebtehal S.
    Shehata, Ihsan A.
    Habib, Elsayed E.
    Ibrahim, Tarek M.
    El-Emam, Ali A.
    EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2010, 45 (11) : 5006 - 5011
  • [25] Synthesis and Antimicrobial and Antioxidant Activities of Some New 5-(2-Methyl-1H-indol-3-yl)-1,3,4-oxadiazol-2-amine Derivatives
    Saundane, Anand R.
    Verma, Vaijinath A.
    Katkar, Vijaykumar T.
    JOURNAL OF CHEMISTRY, 2013, 2013
  • [26] Design, Synthesis and QSAR Studies on a Series of 2, 5-Disubstituted-1,3,4-oxadiazole Derivatives of Diclofenac and Naproxen for Analgesic and Anti-inflammatory Activity
    Ilango, Kaliappan
    Valentina, Parthiban
    Kumar, Gajendra
    Dixit, Dushyant
    Nilewar, Shrikant
    Kathiravan, Muthu K.
    MEDICINAL CHEMISTRY, 2015, 11 (08) : 753 - 763
  • [27] Synthesis and antibacterial activities of 2-(1-aryl-5-methyl-1,2,3-triazol-4-yl)-1,3,4-oxadiazole derivatives
    Zhang, Y
    Qiao, RZ
    Xu, PF
    Zhang, ZY
    Wang, Q
    Mao, LM
    Yu, KB
    JOURNAL OF THE CHINESE CHEMICAL SOCIETY, 2002, 49 (03) : 369 - 373
  • [28] 2-(1,2,4-triazole-5-yl)-1,3,4-oxadiazole as a novel building block for energetic materials
    Dong, Zheting
    Wu, Zhengqiang
    Zhang, Qiang
    Xu, Yuangang
    Lu, Guo-Ping
    FRONTIERS IN CHEMISTRY, 2022, 10
  • [29] Synthesis and anti-proliferative activity in vitro of new 5-(2-amino-3-pyridyl)-2-thioxo-3H-1,3,4-oxadiazole derivatives
    Liszkiewicz, H
    Kowalska, MW
    Wietrzyk, J
    Opolski, A
    INDIAN JOURNAL OF CHEMISTRY SECTION B-ORGANIC CHEMISTRY INCLUDING MEDICINAL CHEMISTRY, 2003, 42 (11): : 2846 - 2852
  • [30] Some Novel Mannich Bases of 5-(3,4-Dichlorophenyl)-1,3,4-oxadiazole-2(3H)-one and Their Anti-Inflammatory Activity
    Koksal, Meric
    Ozkan-Dagliyan, Irem
    Ozyazici, Tugce
    Kadioglu, Beril
    Sipahi, Hande
    Bozkurt, Ayhan
    Bilge, Suleyman S.
    ARCHIV DER PHARMAZIE, 2017, 350 (09)